May 21, 2020
Healthcare workers to participate in chloroquine study
Editor's Note
An international study will include more than 30,000 front-line healthcare workers to assess whether chloroquine can prevent COVID-19 or decrease its severity.
Washington University School of Medicine in St Louis is the clinical coordinating center for the study.
Healthcare workers will be divided randomly into four groups. Three groups will receive chloroquine at various doses, and the fourth group will receive a placebo.
The study will last 5 months.
Free Daily News
- Milestone pig kidney transplant offers hope amid ethical, safety questions
- Fitch Ratings: Hospital credit outlook improves amid stabilizing margins
- Annual Leapfrog Group awards recognize top hospitals, ASCs
- US obesity rates decline for first time in a decade
- Study: Active monitoring without surgery safe for certain low-risk DCIS patients
- Data support option to skip sentinel lymph node biopsy in early breast cancer
- Surveyed nurses, physicians likely to quit
- Costs drop, access expands for GLP-1 weight loss drugs
- Q&A: Perioperative immunotherapy advances for early-stage NSCLC
- Proposals close December 16: Present at the 2025 OR Manager Conference
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement